Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) priced its initial public offering on Aug 31, 2022 at $8.12 per share, raising $10M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $107.9M. Boustead was lead-left underwriter, joined by Valuable Capital. Michelman & Robinson advised the company.

Shuttle Pharmaceuticals Holdings, Inc. is a discovery- and development-stage specialty pharmaceutical company founded in 2012 by Georgetown University Medical Center faculty. It develops radiation sensitizers to improve outcomes for cancer patients treated with radiation therapy.

Status

IPO

Ticker

SHPH

Exchange

Nasdaq Capital Market

Priced

Aug 31, 2022

IPO price

$8.12

Raised

$10M

Market cap at IPO price

$107.9M

First filed

Jun 3, 2022

Underwriters

Boustead and Valuable Capital

Company counsel

Michelman & Robinson

Sector

Biotech & pharma

Country / state

MD

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.